Market Cap (In SEK)
61.58 Million
Revenue (In SEK)
43.89 Million
Net Income (In SEK)
-56.82 Million
Avg. Volume
116.31 Thousand
- Currency
- SEK
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.75-8.4
- PE
- -
- EPS
- -
- Beta Value
- 1.178
- ISIN
- SE0007387089
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Ms. Lone Carlbom
- Employee Count
- -
- Website
- https://www.bio-works.com
- Ipo Date
- 2017-12-14
- Details
- Bio-Works Technologies AB (publ), a biotechnology company, researches, develops, manufactures, and supplies agarose-based separation products to purify proteins, peptides, and other biomolecules primarily in Sweden. It offers activated and affinity resins; BabyBio columns; immobilized metal-ion affinity chromatography resins; ion exchange resins; OptioBio glass columns; screening kits; and size exclusion chromatography resins. The company's products are used in antibodies, his-tagged proteins, proteins, peptides, oligonucleotides, and viruses and vaccines applications. Bio-Works Technologies AB (publ) founded in 2006 and is headquartered in Uppsala, Sweden.
More Stocks
-
300078Hangzhou Century Co., Ltd.
300078
-
FINWizzFinancial
FIN
-
VIRIVIRIDIEN
VIRI
-
BRKA
-
GTK
-
9680
-
HLBBFH. Lundbeck A/S
HLBBF
-
3474G-Factory Co.,Ltd.
3474